Abstract:Molecular glues, functioning via inducing degradation of the target protein while having similar molecular weight as traditional small molecule drugs, are emerging as a promising modality for the development of therapeutic agents. However, the development of molecular glues is limited by the lack of general principles and systematic methods. Not surprisingly, most molecular glues have been identified serendipitously or through phenotypic screening of large libraries. However, the preparation of large and diverse molecular glue libraries is not an easy task and requires extensive resources. We previously developed platforms for rapid synthesis of proteolysis targeting chimeras (PROTACs) that can be used directly for biological screening with minimal resources. Herein, we report a platform of rapid synthesis of molecular glues (Rapid-Glue) via a micromolar scale coupling reaction between hydrazide motif on the E3 ligase ligands and commercially available aldehydes with diverse structures. A pilot library of 1520 compounds is generated under miniaturized conditions in a high throughput manner without any further manipulation including purification after the synthesis. Through this platform, we identified two highly selective GSPT1 molecular glues through direct screening in cell-based assays. Three additional analogues were prepared from readily available starting materials by replacing the hydrolytic labile acylhydrazone linker with a more stable amide linker based on the two hits. All three analogues showed significant GSPT1 degradation activity and two of them possess comparable activity to the corresponding hit. The feasibility of our strategy is thus verified. Further studies by increasing the diversity and size of the library followed by appropriate assays will likely yield distinct molecular glues targeting novel neo-substrates.

Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic

Molecular Glues For Targeted Protein Degradation: From Serendipity To Rational Discovery

Molecular glue-mediated targeted protein degradation: A novel strategy in small-molecule drug development

Targeted Protein Degradation and Regulation with Molecular Glue: Past and Recent Discoveries

Molecular glue degraders: exciting opportunities for novel drug discovery

Advances in molecular glues: exploring chemical space and design principles for targeted protein degradation

Molecular glue degrader for tumor treatment

PROTACs: an Emerging Targeting Technique for Protein Degradation in Drug Discovery

Molecular Glues Modulate Protein Functions by Inducing Protein Aggregation: A Promising Therapeutic Strategy of Small Molecules for Disease Treatment

Molecular Glue Discovery: Current and Future Approaches.

Targeted protein degradation via intramolecular bivalent glues

Targeted protein degradation: from mechanisms to clinic

Charged Molecular Glue Discovery Enabled by Targeted Degron Display

Emerging strategies for prospective discovery of molecular glue degraders

A platform for the rapid synthesis of molecular glues (Rapid-Glue) under miniaturized conditions for direct biological screening

Breaking Bad Proteins—Discovery Approaches and the Road to Clinic for Degraders

Key Considerations in Targeted Protein Degradation Drug Discovery and Development

Protein degraders push into novel target space

Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?

Inducing or enhancing protein-protein interaction to develop drugs: Molecular glues with various biological activity

[Protein induced proximity and targeted degradations by new degraders: concepts, developments, challenges for clinical applications]